
Sign up to save your podcasts
Or


Another day, another b cell podcast. Seems to be all the rage! This week I discuss the recently published NEJM trial of the anti CD20 agent obinutuzumab in lupus nephritis. Worth a read and listen, paper can be found here: https://www.nejm.org/doi/full/10.1056/NEJMoa2410965
By Michael Putman4.9
114114 ratings
Another day, another b cell podcast. Seems to be all the rage! This week I discuss the recently published NEJM trial of the anti CD20 agent obinutuzumab in lupus nephritis. Worth a read and listen, paper can be found here: https://www.nejm.org/doi/full/10.1056/NEJMoa2410965

498 Listeners

298 Listeners

125 Listeners

3,348 Listeners

1,148 Listeners

119 Listeners

194 Listeners

515 Listeners

69 Listeners

4 Listeners

370 Listeners

181 Listeners

185 Listeners

20 Listeners

7 Listeners